ABBOTT LABORATORIES (ABT) Latest Company News

Oct 19, 2026, 11:23 UTC
ABBOTT LABORATORIES is scheduled to release its third-quarter earnings report before the market opens on October 21, 2026.
Source:
- benzinga.com
Oct 12, 2026, 23:00 UTC
ABBOTT LABORATORIES shares closed at $101.82, up 2.23% from the previous trading session.
Source:
- zacks.com
Oct 7, 2026, 13:00 UTC
ABBOTT LABORATORIES introduced Ensure Max Protein 3-in-1 Muscle Support, a powder with 30 grams of protein, 5 grams of creatine monohydrate and 3 grams of calcium HMB per serving, available in chocolate and vanilla at major U.S. retailers.
Source:
- prnewswire.com
Oct 6, 2026, 22:51 UTC
ABBOTT LABORATORIES shares closed at $98.16, down 1.94% from the previous trading session.
Source:
- zacks.com
Oct 6, 2026, 08:45 UTC
Lazada held its annual LazMall Brand Gala 2026, honoring Abbott, Estée Lauder Companies and Samsung as LazMall Brand of the Year among winners across 10 award categories.
Source:
- en.antaranews.com
Oct 5, 2026, 23:59 UTC
FCM Travel Asia expanded its Japan management team, appointing Benjamin Beh as General Manager of FCM Travel Japan, Aki Yonezu as Head of Account Management and Meetings & Events, Norimasa Arase as Sales & Marketing Manager, and Joe Nakazawa as Director of Supplier Relations and Strategic Partnerships at Flight Centre Travel Group in Japan.
Source:
- ttrweekly.com
Oct 5, 2026, 13:00 UTC
Abbott received U.S. FDA approval for updates to its CardioMEMS HF System enabling new patient-facing capabilities through the CardioGuide HF App.
Source:
- prnewswire.com
Sep 30, 2026, 23:45 UTC
Abbott Laboratories agreed to pay $348.7 million to the United States and $35.5 million to 39 states to settle allegations that it sold contaminated infant formula and nutritional products to government health programs, with Mississippi receiving over $770,000 in restitution.
Source:
- supertalk.fm
Sep 24, 2026, 15:45 UTC
Andhra Pradesh IT & HRD Minister Nara Lokesh appealed to Abbott India MD Ishteyaque Amjad to set up a medical devices/diagnostics manufacturing unit in an AP MedTech Zone or electronics manufacturing cluster, a generic drug unit at the Nakkapalli bulk drug park, and an Abbott GCC in Visakhapatnam.
Source:
- thehindu.com
Sep 23, 2026, 11:30 UTC
An FDA advisory committee met to vote on whether the agency should approve Grail's Galleri multi-cancer blood test.
Source:
Sep 23, 2026, 10:00 UTC
Pakistan's Finance Minister Muhammad Aurangzeb met with an Abbott representative in New York to discuss accelerating Pakistan's Hepatitis C eradication programme, pharmaceutical regulation and exports, and Abbott's cancer treatment projects in Pakistan.
Source:
- samaa.tv
Sep 21, 2026, 23:59 UTC
Abbott Laboratories agreed to a $384 million settlement with North Carolina and 39 other states plus the federal government over allegations involving contaminated infant formula tied to the 2022 nationwide baby formula shortage.
Source:
- wsoctv.com
Sep 21, 2026, 23:59 UTC
The Community Blood Center reported a critical Type O blood shortage after Brown County hospitals requested at least 24 emergency units for six patients, with several blood types at only a two-to-three-day supply.
Source:
- duke.fm
Sep 18, 2026, 09:57 UTC
Abbott announced that its FreeStyle Libre 2 received integrated continuous glucose monitoring (iCGM) approval from China's National Medical Products Administration, making it the first and currently only dynamic glucose monitor in China approved to assist adult diabetes treatment decisions.
Source:
- finance.sina.cn
Sep 17, 2026, 16:43 UTC
Abbott's board of directors declared a quarterly common dividend of 63 cents per share, its 411th consecutive quarterly dividend.
Source:
- prnewswire.com
Sep 15, 2026, 10:18 UTC
Flex Ltd. appointed Brian Yoor as a member of its Board of Directors.
Sep 14, 2026, 18:02 UTC
Abbott Laboratories agreed to pay about $385 million to the U.S. Department of Justice to settle allegations over contaminated infant formula and improper claims to federal and state programs.
Source:
Sep 9, 2026, 15:31 UTC
Abbott received FDA approval for its TactiFlex Duo catheter, expanding its atrial fibrillation ablation portfolio with dual PFA and RF energy options in the United States.
Source:
- zacks.com
Aug 31, 2026, 12:00 UTC
Abbott launched Similac 360 Total Care Made With Whole Milk, the first and only ready-to-feed liquid infant formula made with whole milk in the U.S., at a price similar to its existing Similac powdered formula, available online and at major U.S. retailers.
Source:
- prnewswire.com
- wsoctv.com
Aug 28, 2026, 00:18 UTC
China's National Healthcare Security Administration held a symposium on August 27, 2026, with 16 pharmaceutical companies to discuss industry development and gather opinions for the 15th Five-Year Plan period.
Source:
- finance.sina.cn
Aug 27, 2026, 13:03 UTC
Abbott's next-generation Amulet 360™ occluder received CE marking for treating atrial fibrillation patients at risk of stroke.
Source:
- finance.sina.cn
- prnewswire.com
Aug 25, 2026, 18:49 UTC
Abbott received FDA authorization for its Libre Duo 10 Day system, the world's first dual glucose-ketone sensing biowearable for people with diabetes.
Source:
Aug 25, 2026, 08:09 UTC
Gateway Wealth Partners LLC reduced its stake in Abbott Laboratories by 64.3% during the quarter, selling 15,431 shares and retaining 8,564 shares, according to a recent SEC filing.
Source:
- defenseworld.net
Aug 25, 2026, 08:09 UTC
Choreo LLC reduced its stake in Abbott Laboratories by 4.4% during the second quarter, selling 4,580 shares, as disclosed in its 13F filing.
Source:
- defenseworld.net
Aug 25, 2026, 08:09 UTC
Golden Reserve Retirement LLC increased its stake in Abbott Laboratories by 155.2% during the quarter, acquiring 5,557 additional shares to hold 9,138 shares, as disclosed in its Form 13F filing.
Source:
- defenseworld.net
Aug 20, 2026, 19:51 UTC
HealthTab, a subsidiary of Avricore Health, signed a distribution agreement with Abbott to supply and distribute Abbott's point-of-care testing products, including the Afinion 2 Analyzer, in the UK.
Source:
- 360dx.com
Aug 20, 2026, 17:15 UTC
Medtronic's MiniMed Flex insulin pump system, paired with Abbott's 15-day Instinct sensor, is now shipping in the United States.
Source:
- zacks.com
Aug 17, 2026, 09:56 UTC
Fifth Third Wealth Advisors LLC reduced its holdings in Abbott Laboratories by 32.6% during the second quarter, selling 14,830 shares and retaining 30,646 shares, as disclosed in its Form 13F filing.
Source:
- defenseworld.net

Page 1Next →

ABT

ABBOTT LABORATORIES is scheduled to release its third-quarter earnings report before the market opens on October 21, 2026.

ABBOTT LABORATORIES shares closed at $101.82, up 2.23% from the previous trading session.

ABBOTT LABORATORIES introduced Ensure Max Protein 3-in-1 Muscle Support, a powder with 30 grams of protein, 5 grams of creatine monohydrate and 3 grams of calcium HMB per serving, available in chocolate and vanilla at major U.S. retailers.

ABBOTT LABORATORIES shares closed at $98.16, down 1.94% from the previous trading session.

Lazada held its annual LazMall Brand Gala 2026, honoring Abbott, Estée Lauder Companies and Samsung as LazMall Brand of the Year among winners across 10 award categories.

Abbott received U.S. FDA approval for updates to its CardioMEMS HF System enabling new patient-facing capabilities through the CardioGuide HF App.

Abbott Laboratories agreed to pay $348.7 million to the United States and $35.5 million to 39 states to settle allegations that it sold contaminated infant formula and nutritional products to government health programs, with Mississippi receiving over $770,000 in restitution.

Andhra Pradesh IT & HRD Minister Nara Lokesh appealed to Abbott India MD Ishteyaque Amjad to set up a medical devices/diagnostics manufacturing unit in an AP MedTech Zone or electronics manufacturing cluster, a generic drug unit at the Nakkapalli bulk drug park, and an Abbott GCC in Visakhapatnam.

An FDA advisory committee met to vote on whether the agency should approve Grail's Galleri multi-cancer blood test.

Pakistan's Finance Minister Muhammad Aurangzeb met with an Abbott representative in New York to discuss accelerating Pakistan's Hepatitis C eradication programme, pharmaceutical regulation and exports, and Abbott's cancer treatment projects in Pakistan.

Abbott Laboratories agreed to a $384 million settlement with North Carolina and 39 other states plus the federal government over allegations involving contaminated infant formula tied to the 2022 nationwide baby formula shortage.

The Community Blood Center reported a critical Type O blood shortage after Brown County hospitals requested at least 24 emergency units for six patients, with several blood types at only a two-to-three-day supply.

Abbott announced that its FreeStyle Libre 2 received integrated continuous glucose monitoring (iCGM) approval from China's National Medical Products Administration, making it the first and currently only dynamic glucose monitor in China approved to assist adult diabetes treatment decisions.

Abbott's board of directors declared a quarterly common dividend of 63 cents per share, its 411th consecutive quarterly dividend.

Flex Ltd. appointed Brian Yoor as a member of its Board of Directors.

Abbott Laboratories agreed to pay about $385 million to the U.S. Department of Justice to settle allegations over contaminated infant formula and improper claims to federal and state programs.

Abbott received FDA approval for its TactiFlex Duo catheter, expanding its atrial fibrillation ablation portfolio with dual PFA and RF energy options in the United States.

Abbott launched Similac 360 Total Care Made With Whole Milk, the first and only ready-to-feed liquid infant formula made with whole milk in the U.S., at a price similar to its existing Similac powdered formula, available online and at major U.S. retailers.

China's National Healthcare Security Administration held a symposium on August 27, 2026, with 16 pharmaceutical companies to discuss industry development and gather opinions for the 15th Five-Year Plan period.

Abbott's next-generation Amulet 360™ occluder received CE marking for treating atrial fibrillation patients at risk of stroke.

Abbott received FDA authorization for its Libre Duo 10 Day system, the world's first dual glucose-ketone sensing biowearable for people with diabetes.

Gateway Wealth Partners LLC reduced its stake in Abbott Laboratories by 64.3% during the quarter, selling 15,431 shares and retaining 8,564 shares, according to a recent SEC filing.

Choreo LLC reduced its stake in Abbott Laboratories by 4.4% during the second quarter, selling 4,580 shares, as disclosed in its 13F filing.

Golden Reserve Retirement LLC increased its stake in Abbott Laboratories by 155.2% during the quarter, acquiring 5,557 additional shares to hold 9,138 shares, as disclosed in its Form 13F filing.

HealthTab, a subsidiary of Avricore Health, signed a distribution agreement with Abbott to supply and distribute Abbott's point-of-care testing products, including the Afinion 2 Analyzer, in the UK.

Medtronic's MiniMed Flex insulin pump system, paired with Abbott's 15-day Instinct sensor, is now shipping in the United States.

Fifth Third Wealth Advisors LLC reduced its holdings in Abbott Laboratories by 32.6% during the second quarter, selling 14,830 shares and retaining 30,646 shares, as disclosed in its Form 13F filing.